A multiplexed Cas13-based assay with point-of-care attributes for simultaneous COVID-19 diagnosis and variant surveillance

Point-of-care (POC) nucleic acid detection technologies are poised to aid gold-standard technologies in controlling the COVID-19 pandemic, yet shortcomings in the capability to perform critically needed complex detection—such as multiplexed detection for viral variant surveillance—may limit their wi...

Descripción completa

Detalles Bibliográficos
Autores principales: Patchsung, Maturada, Homchan, Aimorn, Aphicho, Kanokpol, Suraritdechachai, Surased, Wanitchanon, Thanyapat, Pattama, Archiraya, Sappakhaw, Khomkrit, Meesawat, Piyachat, Wongsatit, Thanakrit, Athipanyasilp, Artittaya, Jantarug, Krittapas, Athipanyasilp, Niracha, Buahom, Juthamas, Visanpattanasin, Supapat, Niljianskul, Nootaree, Chaiyen, Pimchai, Tinikul, Ruchanok, Wichukchinda, Nuanjun, Mahasirimongkol, Surakameth, Sirijatuphat, Rujipas, Angkasekwinai, Nasikarn, Crone, Michael A., Freemont, Paul S., Joung, Julia, Ladha, Alim, Abudayyeh, Omar, Gootenberg, Jonathan, Zhang, Feng, Chewapreecha, Claire, Chanarat, Sittinan, Horthongkham, Navin, Pakotiprapha, Danaya, Uttamapinant, Chayasith
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7614457/
https://www.ncbi.nlm.nih.gov/pubmed/36367987
http://dx.doi.org/10.1089/crispr.2022.0048

Ejemplares similares

Ejemplares similares